[Thrombolytic therapy for myocardial infarction in oral anticoagulation].
Pizzulli
L
L
Medizinische Universitätsklinik und Poliklinik, Bonn.
Lüderitz
B
B
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D004357:Drug Synergism; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D012306:Risk; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D013300:Streptokinase; D010959:Tissue Plasminogen Activator
Lysetherapie bei Myokardinfarkt unter oraler Antikoagulation?